🎉 NMPA Approval!
#Bireociclib Tablets (#Xuan Yuening) by #Xuanzhu Biopharmaceutical Co., Ltd. are now approved for HR+/HER2– advanced or metastatic breast cancer.

📧 info@dengyuemed.com
#CDK46Inhibitor #HRPositiveBreastCancer #HER2NegativeBreastCancer #NMPAApproval
#HongKongDengYueMedicine